IntelliPharmaCeutics International (IPCI)
Add to Watchlists Create an Alert
1.84
+0.03 +1.72%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
IntelliPharmaCeutics International Free Cash Flow:
-1.456M for Feb. 28, 2013IntelliPharmaCeutics International Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Feb. 28, 2013 | -1.456M |
| Nov. 30, 2012 | -2.318M |
| Aug. 31, 2012 | -1.964M |
| May 31, 2012 | -2.158M |
| Feb. 29, 2012 | -2.250M |
| Nov. 30, 2011 | -1.763M |
| Aug. 31, 2011 | -1.417M |
| May 31, 2011 | -2.057M |
| Feb. 28, 2011 | -2.007M |
| Nov. 30, 2010 | -1.577M |
| Aug. 31, 2010 | -1.592M |
| May 31, 2010 | -0.9343M |
| Feb. 28, 2010 | -2.225M |
| Aug. 31, 2009 | |
| May 31, 2009 | |
| Feb. 28, 2009 | |
| Nov. 30, 2008 | 0.6725M |
| Aug. 31, 2008 | -1.833M |
| May 31, 2008 | -7.566M |
| Feb. 29, 2008 | Go Pro |
| Nov. 30, 2007 | Go Pro |
| Aug. 31, 2007 | Go Pro |
| May 31, 2007 | Go Pro |
| Feb. 28, 2007 | Go Pro |
| Nov. 30, 2006 | Go Pro |
| Aug. 31, 2006 | Go Pro |
| May 31, 2006 | Go Pro |
| Feb. 28, 2006 | Go Pro |
| Nov. 30, 2005 | Go Pro |
| Aug. 31, 2005 | Go Pro |
| May 31, 2005 | Go Pro |
| Feb. 28, 2005 | Go Pro |
| Nov. 30, 2004 | Go Pro |
| Aug. 31, 2004 | Go Pro |
| May 31, 2004 | Go Pro |
| Feb. 29, 2004 | Go Pro |
| Nov. 30, 2003 | Go Pro |
| Aug. 31, 2003 | Go Pro |
| May 31, 2003 | Go Pro |
| Feb. 28, 2003 | Go Pro |
| Nov. 30, 2002 | Go Pro |
| Aug. 31, 2002 | Go Pro |
| May 31, 2002 | Go Pro |
| Feb. 28, 2002 | Go Pro |
| Nov. 30, 2001 | Go Pro |
| Aug. 31, 2001 | Go Pro |
| May 31, 2001 | Go Pro |
| Feb. 28, 2001 | Go Pro |
| Nov. 30, 2000 | Go Pro |
| Aug. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
IPCI Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Celgene Corporation | 341.20M |
| Elan | -28.50M |
| ARCA biopharma | -0.773M |
IPCI Free Cash Flow Rankings
| Overall |
61st percentile 2931 of 7600 |
| Sector |
54th percentile 296 of 653 in Healthcare |
| Industry |
74th percentile 61 of 238 in Biotechnology |
IPCI Free Cash Flow Range, Past 5 Years
| Minimum | -7.566M | May 2008 |
| Maximum | 0.6725M | Nov 2008 |
| Average | -2.028M |
